Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis

Background: Efficient personalized therapy paradigms are needed to modify the disease course and halt gray (GM) and white matter (WM) damage in patients with multiple sclerosis (MS). Presently, promising disease-modifying drugs show impressive efficiency, however, tailored markers of therapy respons...

Full description

Bibliographic Details
Main Authors: Dumitru Ciolac, Felix Luessi, Gabriel Gonzalez-Escamilla, Nabin Koirala, Christian Riedel, Vinzenz Fleischer, Stefan Bittner, Julia Krämer, Sven G. Meuth, Muthuraman Muthuraman, Sergiu Groppa
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01779/full